April 8, 2019
SAKURA 3 Trial Results Presented on Podium at World’s Largest Medical Aesthetic Conference
Unprecedented clinical results for DaxibotulinumtoxinA for Injection(DAXI), Revance’s long-acting neuromodulator, were highlighted at the 17thAesthetics & Anti-Aging Medical World Congress in Monte-Carlo